Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Current Protocols in Cytometry|September 5, 2008
Time-lapse microscopy approaches to track cell cycle progression at the single-cell levelRachel J Errington, Nuria Marquez, Sally C Chappell, et al.Molecular Endocrinology (Baltimore, Md.)|October 18, 2008
A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivoPaul G Tiffen, Nader Omidvar, Nuria Marquez-Almuina, et al.Current Protocols in Cytometry|April 3, 2013
Time-lapse microscopy approaches to track cell cycle and lineage progression at the single-cell levelRachel J Errington, Sally C Chappell, Imtiaz A Khan, et al.Oncogene|October 25, 2003
Single cell tracking reveals that Msh2 is a key component of an early-acting DNA damage-activated G2 checkpointNuria Marquez, Sally C Chappell, Owen J Sansom, et al.Cell Cycle (Georgetown, Tex.)|March 27, 2004
Microtubule stress modifies intra-nuclear location of Msh2 in mouse embryonic fibroblastsNuria Marquez, Sally C Chappell, Owen J Sansom, et al.Cell Cycle (Georgetown, Tex.)|August 28, 2007
Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cellsPaul J Smith, Nuria Marquez, Marie Wiltshire, et al.Blood|October 4, 2013
Overproduction of NOX-derived ROS in AML promotes proliferation and is associated with defective oxidative stress signalingPaul S Hole, Joanna Zabkiewicz, Chinmay Munje, et al.Blood|June 25, 2026
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 TrialSteven Knapper, Abin Thomas, Robert K Hills, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 2024
Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 TrialNigel H Russell, Abin Thomas, Robert K Hills, et al.Blood|August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trialSylvie D Freeman, Abin Thomas, Ian Thomas, et al.Pageof 2